Johnson & Johnson vaccine could be approved for European use by mid-March

Ireland has ordered 2.2 million doses of the Johnson & Johnson vaccine.

The Covid-19 vaccine being developed by Johnson and Johnson has been submitted for approval to the European Medicines Agency (EMA).

EMA’s human medicines committee will assess the vaccine, known as COVID-19 Vaccine Janssen, under an accelerated timetable which could see a decision being made on the single-shot vaccine by the middle of next month.